Delisting risk
Oragenics (OGEN)
Developing an intranasal concussion treatment candidate through outsourced clinical development.
$0.4998
Pre-market−0.02 (−4.62%)
At close$0.5240(+5.01%)
Something off on this page? Send us feedback.
Next report
Nov 16, 2026
estimated · in 74 days
EPS estimate
−$90.00
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$3.30−$3.60−$3.10−$1.96−$0.54−$0.51−$0.57Pending
Estimate———−$144.00−$90.00−$90.00−$90.00−$90.00
Surprise———+98.6%+99.4%+99.4%+99.4%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$90.00 | — | — |
| Aug 2026 | −$90.00 | −$0.57 | +99.4% |
| May 2026 | −$90.00 | −$0.51 | +99.4% |
| Feb 2026 | −$90.00 | −$0.54 | +99.4% |
| Nov 2025 | −$144.00 | −$1.96 | +98.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | −$90.00 | — | — | — | — | — | — |
| Aug 13, 2026 | −$90.00 | −$0.57 | +99.4% | — | — | — | −1.2% |
| May 8, 2026 | −$90.00 | −$0.51 | +99.4% | — | — | — | −6.6% |
| Feb 26, 2026 | −$90.00 | −$0.54 | +99.4% | — | — | — | −4.5% |
| Nov 7, 2025 | −$144.00 | −$1.96 | +98.6% | — | — | — | 0.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 8, 2025 | |||||||
| May 9, 2025 | |||||||
| Mar 14, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 22, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 13, 2022 | |||||||
| Mar 24, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 3, 2021 | |||||||
| Mar 2, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 14, 2020 | |||||||
| May 15, 2020 | |||||||
| Mar 4, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 13, 2019 | |||||||
| Mar 29, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 13, 2018 | |||||||
| May 15, 2018 | |||||||
| Feb 16, 2018 | |||||||
| Oct 31, 2017 | |||||||
| Aug 14, 2017 | |||||||
| May 15, 2017 | |||||||
| Feb 27, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 15, 2016 | |||||||
| May 16, 2016 | |||||||
| Mar 30, 2016 | |||||||
| Nov 6, 2015 | |||||||
| Aug 7, 2015 | |||||||